Client Alerts & Insights
Benesch COVID-19 Resource Center: SEC Relief for Investment Advisers
March 18, 2020
On March 13, 2020, the Securities and Exchange Commission (the “SEC”) issued an order providing certain conditional relief for upcoming filings for investment advisers, both advisers registered under the Investment Advisers Act of 1940, as amended, and exempt reporting advisers.
This conditional relief applies to certain filings of investment advisers that would have been due between March 13 and April 30, 2020. In particular, the order provides conditional relief for Form ADV and Form PF filings for registered investment advisers and exempt reporting advisers.
The conditions of the relief are as follows:
- The registered investment adviser or exempt reporting adviser is unable to meet the filing deadline or delivery requirement as a result of the COVID-19 outbreak; and
- With respect to the filing of Form ADV or delivery of its brochure (or summary of material changes) or brochure supplement, an investment adviser seeking to use the filing extension must e-mail the SEC at IARDLive@sec.gov and disclose on its public website (or, if the adviser does not have a public website, promptly notify its clients and/or private fund investors) the following information:
- The fact that the adviser is relying on the SEC’s order;
- Briefly, why the adviser could not file or deliver its Form ADV; and
- When the adviser estimates it will be able to file or deliver its Form ADV.
- With respect to the filing of Form PF, an investment adviser seeking to use the filing extension must – similar to the above – email the SEC at IARDLive@sec.gov and provide the following information:
- The fact that the adviser is relying on the SEC’s order;
- Briefly, why the adviser could not file its Form PF; and
- When the adviser estimates it will be able to file its Form PF.
With respect to both the Form ADV and Form PF, the investment adviser must file both (and deliver its brochure and brochure supplement) as soon as practicable, but in no event later than 45 days after the original due date.
The order can be found here.
If you have any questions regarding the above, please contact a member of Benesch’s Corporate & Securities Practice Group.
Sarah M. Hesse at shesse@beneschlaw.com or 312.212.4966.
***
Please note that this information is current as of the date of this Client Alert, based on the available data. However, because COVID-19’s status and updates related to the same are ongoing, we recommend real-time review of guidance distributed by the CDC and local officials.

Latest News
FTC Enforcement Trends in 2026: What Businesses, Advertisers Should Be Watching Now
Regulators continue to signal a return to core consumer‑friendly principles through new rulemaking initiatives, and recent enforcement activity, warning letters, and public commentary offer a practical preview of where scrutiny is likely to concentrate in 2026…
IEEPA Tariffs – Top Five Q&A for Supply Chains after U.S. Supreme Court Decision
The U.S. Supreme Court issued its highly anticipated decision regarding tariffs Friday. The Court held that the International Emergency Economic Powers Act (“IEEPA”) does not authorize the President to impose tariffs according to the 6-3 decision…
Watch Your T&Cs! When Done Right, Terms and Conditions are Both Viable—And Valuable
The era of the paper/hard copy bill of lading and/or rate confirmation is fading fast. Hard copies and paper do live on in various shipment schematics; however, increasingly, and at a very rapid rate, transactions between shippers, carriers, brokers and forwarders are conducted by, and memorialized in, electronic form via email, interactive website access and response, and—more and more—AI mechanisms.
The Long Tail of the Opioid Crisis: How AGs Continue to Pursue Manufacturers, Distributors, Pharmacies
The opioid crisis has been a perennial priority for state attorneys general, and was the marquis priority for the National Association of Attorneys General (NAAG) in both 2023 (under OH AG Dave Yost) and 2025 (under NH AG John Formella). Recently, Texas Attorney General Ken Paxton announced the conclusion of a multistate effort to secure the bankruptcy reorganization plan for Purdue Pharma (Purdue).